STRUCTURE-ACTIVITY RELATIONSHIP STUDIES WITH SYMMETRICAL NAPHTHALENESULFONIC ACID-DERIVATIVES - SYNTHESIS AND INFLUENCE OF SPACER AND NAPHTHALENESULFONIC ACID MOIETY ON ANTI-HIV-1 ACTIVITY
P. Mohan et al., STRUCTURE-ACTIVITY RELATIONSHIP STUDIES WITH SYMMETRICAL NAPHTHALENESULFONIC ACID-DERIVATIVES - SYNTHESIS AND INFLUENCE OF SPACER AND NAPHTHALENESULFONIC ACID MOIETY ON ANTI-HIV-1 ACTIVITY, Journal of medicinal chemistry, 36(14), 1993, pp. 1996-2003
Symmetric bis(naphthalenesulfonic acid) derivatives containing a varie
ty of spacers have been synthesized and evaluated for anti-HIV-1 activ
ity in four assay systems. In the assay that measured inhibition of HI
V-1-induced cytopathogenicity using a laboratory strain (HTLV-III(B)),
a hexamethylene and octamethylene spacer derivative of 4-amino-5-hydr
oxy-2,7-naphthalenedisulfonic acid emerged as the most potent derivati
ves. The hexamethylene spacer analog exhibited an in vitro therapeutic
index that was > 120. Selected derivatives were tested in the giant c
ell formation assay. In this assay, the most potent derivative was, ag
ain, the hexamethylene compound. Evaluation of selected derivatives ag
ainst a clinical isolate of HIV-1 (HE strain) revealed that the hexame
thylene derivative was the most potent compound. In the assay that mea
sured the inhibition of HIV-1-induced cytopathogenesis in human periph
eral blood lymphocytes, the hexamethylene compound emerged as the most
active derivative, demonstrating a 50% inhibitory concentration of 1.
3 muM. These studies clearly demonstrate that certain naphthalenesulfo
nic acid moieties when coupled to specific spacers were synergistic in
producing anti-HIV-1 activity at nontoxic concentrations. In the 4-am
ino-5-hydroxy-2,7-naphthalenedisulfonic acid series, shortening of the
spacer length, preferably with a flexible polymethylene chain, was hi
ghly beneficial for increasing anti-HIV-1 potency.